SEC Form 4 · accession 0001144204-15-012339
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip S Low
Officer — Chief Science Officer · Director
Period of report
Feb 10, 2015
Accepted (ET)
Feb 26, 2015 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 10, 2015 | M | 544 | $1.91 | A | 198,109 | D | |
| Common Stock | holding | — | — | — | 193,318 | I | By spouse trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.91 | Feb 10, 2015 | M | 544 | D | — | Feb 10, 2015 | Common Stock | 544 | 0 | D |
Explanation of responses
- F1The shares were acquired through the exercise of stock options pursuant to a written plan, entered into by the reporting person on June 26, 2014, as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- F2The option is fully vested and immediately exercisable.